(571) 447-5500

EAS independent consultant, Kaiser Aziz discussed FDA’s Quality Risk Management Approach to New Drug Applications in Drug Development and Delivery. Risk management is one of the most important tools in new drug applications to assess the risk level of a drug product and promotes quality through increased efficiency and knowledge transfer, he says.

Posted in Drugs, EAS in Action, EASeNews.